Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: Development of hollow ferrogadolinium nanonetworks for dual-modal MRI guided cancer chemotherapy

Ting Tangab, Xiao Sun*c, Xuedong Xud, Yifeng Biana, Xiaojie Maa and Ning Chen*a
aJiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, 210029, China. E-mail: dentistchenning@126.com
bDepartment of Dental Implantology, Hefei Stomatology Hospital, Clinical School of Anhui Medical University, Hefei, 230001, China
cDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore 117585, Singapore. E-mail: xiaosun8000@163.com
dChina Shijiazhuang Pharmaceutical Group Co., Ltd., Shijiazhuang, 050038, China

Received 25th February 2019 , Accepted 25th February 2019

First published on 5th March 2019


Abstract

Correction for ‘Development of hollow ferrogadolinium nanonetworks for dual-modal MRI guided cancer chemotherapy’ by Ting Tang et al., RSC Adv., 2019, 9, 2559–2566.


The authors regret that Scheme 1 in the original article included some incorrect data under the cancer chemotherapy part of the scheme. The correct version of Scheme 1 is presented below.
image file: c9ra90017a-s1.tif
Scheme 1

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2019